Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12611000451909Phase 4Not yet recruiting
Phase 4, open-label trial of propofol in childhood obesity (2 arms), sponsored by Auckland City Hospital. Primary endpoint: Arterial blood concentration of propofol versus time. Planned start Nov 2011; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12611000451909.